- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- homo-trimer
- Ligands
- 10 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 12 x NAG- NAG- BMA: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
NAG-NAG-BMA.2: 5 residues within 4Å:- Chain A: N.319, E.320, N.321, T.323
- Chain C: K.597
No protein-ligand interaction detected (PLIP)NAG-NAG-BMA.4: 3 residues within 4Å:- Chain A: I.1171, V.1172, N.1173
No protein-ligand interaction detected (PLIP)NAG-NAG-BMA.6: 5 residues within 4Å:- Chain A: P.369, N.370, P.618, Q.619, T.620
No protein-ligand interaction detected (PLIP)NAG-NAG-BMA.7: 5 residues within 4Å:- Chain A: N.756, T.758, L.961, Q.965, Q.1110
No protein-ligand interaction detected (PLIP)NAG-NAG-BMA.13: 3 residues within 4Å:- Chain A: K.597
- Chain B: E.320, N.321
No protein-ligand interaction detected (PLIP)NAG-NAG-BMA.17: 4 residues within 4Å:- Chain B: G.378, F.381, N.382, V.406
No protein-ligand interaction detected (PLIP)NAG-NAG-BMA.23: 3 residues within 4Å:- Chain B: K.597
- Chain C: E.320, N.321
No protein-ligand interaction detected (PLIP)NAG-NAG-BMA.25: 11 residues within 4Å:- Chain B: F.525, N.526, Y.528
- Chain C: F.377, G.378, F.381, N.382, V.406, L.407, S.410, F.413
1 PLIP interactions:1 interactions with chain C- Hydrophobic interactions: C:V.406
NAG-NAG-BMA.26: 4 residues within 4Å:- Chain A: I.833, D.835
- Chain C: N.748, N.749
No protein-ligand interaction detected (PLIP)NAG-NAG-BMA.27: 3 residues within 4Å:- Chain C: I.1171, V.1172, N.1173
No protein-ligand interaction detected (PLIP)NAG-NAG-BMA.29: 4 residues within 4Å:- Chain C: T.147, T.148, N.273, T.275
No protein-ligand interaction detected (PLIP)NAG-NAG-BMA.30: 7 residues within 4Å:- Chain C: N.756, F.757, T.758, L.961, N.964, Q.965, Q.1110
1 PLIP interactions:1 interactions with chain C- Hydrogen bonds: C:N.964
- 2 x NAG- NAG- BMA- MAN- MAN: alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 1 x NAG- NAG- BMA- FUC: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose
- 2 x NAG- NAG- BMA- MAN- FUC: alpha-D-mannopyranose-(1-3)-beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose
NAG-NAG-BMA-MAN-FUC.12: 5 residues within 4Å:- Chain A: N.1137, T.1139, F.1142, Y.1149, I.1153
3 PLIP interactions:3 interactions with chain A- Hydrophobic interactions: A:T.1139
- Hydrogen bonds: A:N.1137, A:Y.1149, A:Y.1149
NAG-NAG-BMA-MAN-FUC.33: 5 residues within 4Å:- Chain C: N.1137, T.1139, H.1140, F.1142, I.1153
No protein-ligand interaction detected (PLIP)- 2 x NAG- NAG- BMA- MAN: alpha-D-mannopyranose-(1-3)-beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 1 x NAG- NAG- BMA- MAN: alpha-D-mannopyranose-(1-6)-beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 2 x NAG- NAG- FUC: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose
NAG-NAG-FUC.21: 7 residues within 4Å:- Chain B: S.743, V.744, A.745, E.1111, K.1112, N.1113
- Chain C: Q.934
1 PLIP interactions:1 interactions with chain B- Hydrogen bonds: B:N.1113
NAG-NAG-FUC.32: 10 residues within 4Å:- Chain A: L.933, Q.934
- Chain C: S.743, V.744, A.745, S.750, A.752, E.1111, K.1112, N.1113
2 PLIP interactions:1 interactions with chain A, 1 interactions with chain C- Hydrogen bonds: A:Q.934, C:N.1113
- 1 x NAG- NAG- BMA- MAN- MAN- FUC: alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose
- 17 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
NAG.34: 2 residues within 4Å:- Chain A: H.694, N.696
Ligand excluded by PLIPNAG.35: 7 residues within 4Å:- Chain A: N.161, A.162, T.163, N.164, V.166, K.168, V.210
Ligand excluded by PLIPNAG.36: 2 residues within 4Å:- Chain A: N.203, N.204
Ligand excluded by PLIPNAG.37: 4 residues within 4Å:- Chain A: K.349, G.640, N.642, T.643
Ligand excluded by PLIPNAG.38: 5 residues within 4Å:- Chain B: Y.67, N.69, F.98, S.99, N.100
Ligand excluded by PLIPNAG.39: 3 residues within 4Å:- Chain B: G.271, I.272, N.273
Ligand excluded by PLIPNAG.40: 2 residues within 4Å:- Chain B: N.642, T.643
Ligand excluded by PLIPNAG.41: 3 residues within 4Å:- Chain B: H.694, V.695, N.696
Ligand excluded by PLIPNAG.42: 3 residues within 4Å:- Chain B: E.171, N.203, N.204
Ligand excluded by PLIPNAG.43: 2 residues within 4Å:- Chain B: N.370, Q.619
Ligand excluded by PLIPNAG.44: 9 residues within 4Å:- Chain B: Y.183, Y.184, H.185, K.186, N.187, N.188, S.190, W.191, M.192
Ligand excluded by PLIPNAG.45: 3 residues within 4Å:- Chain C: Y.67, S.99, N.100
Ligand excluded by PLIPNAG.46: 3 residues within 4Å:- Chain C: N.188, K.189, S.190
Ligand excluded by PLIPNAG.47: 1 residues within 4Å:- Chain C: N.696
Ligand excluded by PLIPNAG.48: 2 residues within 4Å:- Chain C: N.642, T.643
Ligand excluded by PLIPNAG.49: 7 residues within 4Å:- Chain C: V.159, N.161, T.163, N.164, V.166, E.193, Y.199
Ligand excluded by PLIPNAG.50: 2 residues within 4Å:- Chain C: N.370, Q.619
Ligand excluded by PLIP- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Singh, S. et al., SARS CoV-2 full-length spike protein with His1271Lys substitution in the coatomer binding motif, 1RBD-up conformation. To Be Published
- Release Date
- 2025-04-16
- Peptides
- Spike glycoprotein: ABC
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
C
- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- homo-trimer
- Ligands
- 10 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 12 x NAG- NAG- BMA: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 2 x NAG- NAG- BMA- MAN- MAN: alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 1 x NAG- NAG- BMA- FUC: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose
- 2 x NAG- NAG- BMA- MAN- FUC: alpha-D-mannopyranose-(1-3)-beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose
- 2 x NAG- NAG- BMA- MAN: alpha-D-mannopyranose-(1-3)-beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 1 x NAG- NAG- BMA- MAN: alpha-D-mannopyranose-(1-6)-beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 2 x NAG- NAG- FUC: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose
- 1 x NAG- NAG- BMA- MAN- MAN- FUC: alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose
- 17 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Singh, S. et al., SARS CoV-2 full-length spike protein with His1271Lys substitution in the coatomer binding motif, 1RBD-up conformation. To Be Published
- Release Date
- 2025-04-16
- Peptides
- Spike glycoprotein: ABC
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
C